TY  - JOUR
AU  - Sereno, María
AU  - Gutiérrez Gutiérrez, Gerardo
AU  - Moreno Rubio, Juan
AU  - Apellániz Ruiz, María
AU  - Sánchez Barroso, Lara
AU  - Casado, Enrique
AU  - Falagan, Sandra
AU  - López Gómez, Miriam
AU  - Merino, María
AU  - Gómez Raposo, César
AU  - Rodriguez Salas, Nuria
AU  - Zambrana Tébar, Francisco
AU  - Rodríguez Antona, Cristina
PY  - 2017
DO  - 10.1186/s12885-016-3031-5
SN  - 1471-2407
UR  - https://hdl.handle.net/20.500.14352/94396
T2  - BMC Cancer
AB  - Background: Oxaliplatin is a chemotherapy agent active against digestive tumors. Peripheral neuropathy is one of the most important dose-limiting toxicity of this drug. It occurs in around 60–80% of the patients, and 15% of them develop severe...
LA  - eng
M2  - 63
PB  - Springer Nature
KW  - Oxaliplatin neuropathy
KW  - Calcium channel
KW  - SCN9A
TI  - Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy
TY  - journal article
VL  - 17
ER  -